Article
Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Oncogene - 1 May 2014
Ai J, Pascal L E, O'Malley K J, Dar J A, Isharwal S, Qiao Z, Ren B, Rigatti L H, Dhir R, Xiao W, Nelson J B, Wang Z
Abstract excerpt
Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor genes phosphatase and tensin homolog deleted on chromosome 10 (Pten) and androgen upregulated gene 19 (U19), which encodes ELL-associated factor 2 (EAF2), are frequently inactivated or downregulated in advanced prostate cancers. Previous studies showed that EAF2 knockout caused tumors in multiple organs and prostatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
